Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-03 08:30 am Purchase | 2026-06-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Management, L.L.C. | 5,917,400 9.900% | 5,917,400 (New Position) | Filing History |
| 2026-07-02 4:04 pm Purchase | 2026-06-25 | 13G | AGIOS PHARMACEUTICALS INC AGIO | D. E. Shaw & Co., L.P. | 3,034,031 5.100% | 3,034,031 (New Position) | Filing History |
| 2026-05-15 11:01 am Sale | 2026-03-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Armistice Capital, LLC | 2,716,000 4.570% | -320,000 (-10.54%) | Filing History |
| 2026-05-06 4:21 pm Purchase | 2026-04-29 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Lynx1 Capital Management LP | 3,013,949 5.100% | 3,013,949 (New Position) | Filing History |
| 2026-04-29 4:38 pm Purchase | 2026-03-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Vanguard Capital Management | 3,088,169 5.270% | 3,088,169 (New Position) | Filing History |
| 2026-03-26 3:12 pm Sale | 2026-03-13 | 13G | AGIOS PHARMACEUTICALS INC AGIO | VANGUARD GROUP INC | 0 0.000% | -5,599,917 (Position Closed) | Filing History |
| 2026-02-17 9:54 pm Purchase | 2025-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Armistice Capital, LLC | 3,036,000 5.210% | 828,930 (+37.56%) | Filing History |
| 2026-02-09 08:54 am Sale | 2025-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 5,159,505 8.800% | -514,961 (-9.08%) | Filing History |
| 2026-02-09 06:15 am Purchase | 2025-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | STATE STREET CORP STT | 3,108,145 5.300% | 482,460 (+18.37%) | Filing History |
| 2025-12-05 5:42 pm Sale | 2025-11-19 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Bellevue Group AG | 0 0.000% | -3,515,150 (Position Closed) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Paradigm BioCapital Advisors LP | 2,873,555 4.900% | -154,422 (-5.10%) | Filing History |
| 2025-08-28 4:31 pm Purchase | 2025-08-21 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Paradigm BioCapital Advisors LP | 3,027,977 5.200% | 3,027,977 (New Position) | Filing History |
| 2025-07-17 7:44 pm Sale | 2025-06-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | BlackRock, Inc. BLK | 4,513,170 7.800% | -449,067 (-9.05%) | Filing History |
| 2025-07-07 7:32 pm Purchase | 2025-06-01 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Bellevue Group AG | 3,515,150 6.100% | 3,515,150 (New Position) | Filing History |
| 2025-06-13 2:50 pm Sale | 2025-06-01 | 13G | AGIOS PHARMACEUTICALS INC AGIO | BB BIOTECH AG | 0 0.000% | -3,515,150 (Position Closed) | Filing History |
| 2025-02-14 2:35 pm Sale | 2024-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | BB BIOTECH AG | 3,515,150 6.200% | -484,850 (-12.12%) | Filing History |
| 2025-02-04 12:02 pm Purchase | 2024-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 5,674,466 9.900% | 13,600 (+0.24%) | Filing History |
| 2024-11-14 3:44 pm Sale | 2024-09-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Armistice Capital, LLC | 2,207,070 3.880% | -1,316,930 (-37.37%) | Filing History |
| 2024-11-08 2:40 pm Purchase | 2024-09-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 5,660,866 9.900% | 1,493,264 (+35.83%) | Filing History |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Armistice Capital, LLC | 3,524,000 6.310% | 774,000 (+28.15%) | Filing History |